Insomnia – Pipeline Assessment and Market Forecasts to 2017
Insomnia – Pipeline Assessment and Market Forecasts to 2017
Article by Aarkstore Enterprise
Aarkstore announce a new report “Insomnia – Pipeline Assessment and Market Forecasts to 2017 ” through its vast collection of market research report.
Insomnia – Pipeline Assessment and Market Forecasts to 2017 report is an essential source of information and analysis on the global Insomnia market. The report identifies the key trends shaping and driving the global Insomnia market.
The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Insomnia sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
We estimated the global insomnia market to be valued at .75 billion in 2009. It is forecast to decline at a Compound Annual Growth Rate (CAGR) of -3.2% over the next seven years to reach .12 billion by 2017. The decline will be mainly due to the patent expiry of many drugs. Barriers to the insomnia market are strong in terms of both pricing (generics and me-too compounds in the market) and volume, with issues such as the low treatment-seeking rate and a low diagnosis rate, amongst others
Scope
The report provides information on the key drivers and challenges of the Insomnia market. Its scope includes:- Annualized global Insomnia market revenues data from 2001 to 2009, forecast for eight years to 2017.- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as Serotonin receptor antagonists, Melatonin receptor agonists, GABA receptor modulators, Orexin receptor antagonists, 5-HT2A and histamine receptor antagonists and Phosphoprotien modulators.- Analysis of the current and future competition in the global Insomnia market. Key market players covered are Bayer Healtcare Pharmaceuticals, Pfizer Inc, GlaxoSmithKline, Takeda Pharmaceuticals, Actelion Ltd., Eli Lilly and Company and Vanda Pharmaceuticals.- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Insomnia therapeutics market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.- Develop business strategies by understanding the trends shaping and driving the global Insomnia market.- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Insomnia market in future.- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum best opportunities for consolidations, investments and strategic partnerships.- What’s the next big thing in the global Insomnia insomnia market landscape? – Identify, understand and capitalize.
For more information, please visit:http://www.aarkstore.com/reports/Insomnia-Pipeline-Assessment-and-Market-Forecasts-to-2017-76537.htmlOr email us at press@aarkstore.com or call +919272852585
About the Author
Aarkstore Enterprise specialize in providing online market business information on market research reports, books, magazines, conference booking at competitive prices, and strive to provide excellent and innovative service to our customers.
Research and Markets: Argentina Patient Monitoring and Diagnostic Systems Market Assessment and Forecasts to 2015
Research and Markets: Argentina Patient Monitoring and Diagnostic Systems Market Assessment and Forecasts to 2015
Research and Markets has announced the addition of the “Argentina Patient Monitoring and Diagnostic Systems Market Assessment and Forecasts to 2015″ report to their offering.
Read more on Business Wire via Yahoo! Finance
After-school snacks common: U.S. survey
Snacking is common among American children, but fewer families are eating out, a new survey suggests.
Read more on CBC.ca
Smoking in pregnancy could increase baby’s sudden death risk
Babies whose mothers smoke during pregnancy have a far higher risk of Sudden Infant Death Syndrome, now researchers think they know why.
Read more on Daily Mail
Categories: News Tags: 2015, Argentina, Assessment, Diagnostic, Forecasts, MARKET, Markets, Monitoring, patient, research, Systems
NO SNORE STOP SNORING TRAY SLEEP APNEA BEST ON MARKET
NO SNORE STOP SNORING TRAY SLEEP APNEA BEST ON MARKET
- The No Snore tray will reduce or stop snoring entirely
- Fits 98% of people without adjustment
- No impressions or boil and bite required
- Easy Cleaning, simply immerse in hot water
- Travel case included
No Snore
The best selling anti snore device in Europe is now available in the USA for the first time. Designed by European dental experts, the No Snore is proudly made here in Florida USA.
* The appliance is soft and gentle made of FDA approved fle
Price: $ 19.95

